Brief: Nordic Nanovector Explores Strategic Options, Changes CEO

Thor Medical ASA

26/08/2022 15:49

Aug 26 (Reuters) - Nordic Nanovector ASA  NANOVN.OL :
    * CONSOLIDATES SENIOR LEADERSHIP TEAM AND RESTRUCTURES TO
CONSERVE
RESOURCES AS IT EXPLORES STRATEGIC OPTIONS
    * FURTHER TO DECISIONS TO DISCONTINUE PARADIGME STUDY FOR
ITS LEAD
ASSET BETALUTIN(®), RESTRUCTURE COMPANY AND APPOINT CARNEGIE
INVESTMENT BANK TO EXPLORE STRATEGIC OPTIONS
    * SENIOR LEADERSHIP TEAM WILL BE CONSOLIDATED, AND CURRENT
CHIEF
EXECUTIVE OFFICER ERIK SKULLERUD WILL TRANSITION OUT OF HIS ROLE
    * CHIEF FINANCIAL OFFICER MALENE BRONDBERG WILL ASSUME
COMBINED
POSITION OF CFO AND INTERIM CEO

Source text for Eikon:  ID:nWkrn3dP9 
Further company coverage:  NANOVN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))